These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28452903)

  • 1. Zonisamide in Brain Tumor-Related Epilepsy: An Observational Pilot Study.
    Maschio M; Dinapoli L; Zarabla A; Maialetti A; Giannarelli D; Fabi A; Vidiri A; Cantelmi T
    Clin Neuropharmacol; 2017; 40(3):113-119. PubMed ID: 28452903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
    Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
    Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of zonisamide as add-on in brain tumor-related epilepsy: preliminary report.
    Maschio M; Dinapoli L; Saveriano F; Pompili A; Carapella CM; Vidiri A; Jandolo B
    Acta Neurol Scand; 2009 Sep; 120(3):210-2. PubMed ID: 19719809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pregabalin add-on treatment on seizure control, quality of life, and anxiety in patients with brain tumour-related epilepsy: a pilot study.
    Maschio M; Dinapoli L; Sperati F; Pace A; Fabi A; Vidiri A; Pompili A; Carapella CM
    Epileptic Disord; 2012 Dec; 14(4):388-97. PubMed ID: 23248037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxcarbazepine monotherapy in patients with brain tumor-related epilepsy: open-label pilot study for assessing the efficacy, tolerability and impact on quality of life.
    Maschio M; Dinapoli L; Sperati F; Fabi A; Pace A; Vidiri A; Muti P
    J Neurooncol; 2012 Feb; 106(3):651-6. PubMed ID: 21847705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodal pathway for brain tumor-related epilepsy patients: Observational study.
    Maialetti A; Maschio M; Zarabla A; Polimadei C; Papa E; Villani V; Giannarelli D
    Acta Neurol Scand; 2020 Jun; 141(6):450-462. PubMed ID: 32043558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retention, dosing, tolerability and patient reported seizure outcome of Zonisamide as only add-on treatment under real-life conditions in adult patients with partial onset seizures: Results of the observational study ZOOM.
    Hamer H; Baulac M; McMurray R; Kockelmann E
    Seizure; 2016 Jan; 34():66-73. PubMed ID: 26735004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management and monitoring of patients treated with zonisamide: the OZONE study.
    Dupont S; Biraben A; Lavernhe G; Marquet T; Allaf B
    Epileptic Disord; 2013 Sep; 15(3):278-88. PubMed ID: 23906691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life in patients with partial-onset seizures under adjunctive therapy with zonisamide: results from a prospective non-interventional surveillance study.
    Helmstaedter C; Stefan H; Witt JA
    Epileptic Disord; 2011 Sep; 13(3):263-76. PubMed ID: 21914589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perampanel in brain tumor-related epilepsy: Observational pilot study.
    Maschio M; Zarabla A; Maialetti A; Giannarelli D; Koudriavtseva T; Villani V; Zannino S
    Brain Behav; 2020 Jun; 10(6):e01612. PubMed ID: 32285623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zonisamide in children and young adults with refractory epilepsy: an open label, multicenter Italian study.
    Coppola G; Grosso S; Verrotti A; Parisi P; Luchetti A; Franzoni E; Mangano S; Pelliccia A; Operto FF; Iannetti P; Curatolo P; Balestri P; Pascotto A
    Epilepsy Res; 2009 Feb; 83(2-3):112-6. PubMed ID: 19081227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of adjunctive therapy with zonisamide in childhood intractable epilepsy.
    Lee YJ; Kang HC; Seo JH; Lee JS; Kim HD
    Brain Dev; 2010 Mar; 32(3):208-12. PubMed ID: 19304420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight of epilepsy in brain tumor patients.
    Maschio M; Sperati F; Dinapoli L; Vidiri A; Fabi A; Pace A; Pompili A; Carapella CM; Cantelmi T
    J Neurooncol; 2014 Jun; 118(2):385-393. PubMed ID: 24789254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
    Shinnar S; Pellock JM; Conry JA
    Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retention rate of zonisamide in intractable epilepsy.
    Nakken KO; Lindstrøm P; Andersen H
    Acta Neurol Scand; 2015 May; 131(5):268-74. PubMed ID: 25644477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zonisamide in the management of epilepsy in the elderly.
    Romigi A; Femia EA; Fattore C; Vitrani G; Di Gennaro G; Franco V
    Clin Interv Aging; 2015; 10():931-7. PubMed ID: 26089654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zonisamide for refractory juvenile absence epilepsy.
    Velizarova R; Crespel A; Genton P; Serafini A; Gelisse P
    Epilepsy Res; 2014 Sep; 108(7):1263-6. PubMed ID: 24907183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and tolerability of lacosamide as add-on therapy in patients with brain tumor-related epilepsy: Results from a prospective, noninterventional study in European clinical practice (VIBES).
    Rudà R; Houillier C; Maschio M; Reijneveld JC; Hellot S; De Backer M; Chan J; Joeres L; Leunikava I; Glas M; Grant R
    Epilepsia; 2020 Apr; 61(4):647-656. PubMed ID: 32329527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between zonisamide and conventional antiepileptic drugs in the mouse maximal electroshock test model.
    Borowicz KK; Luszczki JJ; Sobieszek G; Ratnaraj N; Patsalos PN; Czuczwar SJ
    Eur Neuropsychopharmacol; 2007 Mar; 17(4):265-72. PubMed ID: 16876388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term retention rate of zonisamide in patients with epilepsy: an observational study.
    Kim DW; Choi K; Moon HS; Oh J
    Clin Neuropharmacol; 2014; 37(5):133-5. PubMed ID: 25229169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.